U.S. Tech Hardware Stock News

NYSE:BKE
NYSE:BKESpecialty Retail

Top 3 Dividend Stocks To Consider In Your Portfolio

As the U.S. stock market begins February on a high note, with major indices like the Dow Jones and S&P 500 posting significant gains, investors are keenly observing how economic developments such as trade deals and government policies will influence future performance. In this dynamic environment, dividend stocks can offer stability and income potential, making them a compelling consideration for those looking to diversify their portfolios amidst fluctuating market conditions.
NYSE:LLY
NYSE:LLYPharmaceuticals

US Stock Market Today: S&P 500 Futures Edge Higher As Growth Outweighs Rate Worries

The Morning Bull - US Market Morning Update Thursday, Feb, 5 2026 US stock futures are slightly higher this morning, with E mini S&P 500 contracts up about 0.1%, as investors weigh firm growth against higher borrowing costs. The US 10 year Treasury yield is holding near a 5 month high, which tends to keep mortgages, credit cards, and corporate borrowing more expensive. At the same time, the S&P Global Composite PMI sits at 53.0 and the Services PMI at 52.7, readings that point to steady...
NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

Upgraded Profitability Targets And Buybacks Might Change The Case For Investing In Cimpress (CMPR)

Cimpress recently reported its second-quarter 2025 results, showing higher year-over-year sales and updated fiscal 2026 guidance that raised its adjusted EBITDA outlook to at least US$460 million, while reiterating longer-term 2028 targets including US$200 million in net income. Together with the completion of a share repurchase program that retired 6.77% of its shares, this guidance underscored management’s confidence in Cimpress’s earnings power and capital allocation approach. We’ll now...
NYSE:MSM
NYSE:MSMTrade Distributors

MSC Industrial Direct (MSM) Q1 Beat And Extended Stock Plan: What Is Management Really Signaling?

In early February 2026, MSC Industrial Direct reported first-quarter fiscal 2026 earnings that exceeded analyst expectations on both EPS and revenue, while shareholders approved an expansion and extension of the Associate Stock Purchase Plan through 2035. This combination of operational outperformance, capital return via buybacks, and long-term employee ownership incentives highlights management’s focus on reinforcing the company’s competitive position and financial discipline. With strong...
NasdaqGS:CARG
NasdaqGS:CARGInteractive Media and Services

CarGurus (CARG) Valuation Check After Recent Share Price Weakness And Longer Term Gains

CarGurus overview after recent share performance CarGurus (CARG) has drawn fresh attention after a recent stretch of weak share performance, including negative moves over the past month and past 3 months, prompting investors to reassess the online auto marketplace’s fundamentals. See our latest analysis for CarGurus. The recent 7 day share price return of 13.38% decline and 30 day share price return of 23.51% decline, alongside a 1 year total shareholder return of 26.89% decline but 3 year...
NYSE:RH
NYSE:RHSpecialty Retail

RH (NYSE:RH) Valuation Check After Growth Plans And New Experiential Concepts

RH (RH) has been back on investors’ radar after its latest quarterly update, which showed 9% year-over-year revenue growth, market share gains, and fresh expansion plans across galleries, design services, and experiential concepts such as RH Ocean Grill. See our latest analysis for RH. That update came on top of a 90 day share price return of 30.77% and a 1 day move of 3.68% to US$206.70, although the 1 year total shareholder return of 50.16% decline shows recent momentum follows a much...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Does WuXi Trispecific T-cell Engager Deal Reshape the Bull Case for Vertex Pharmaceuticals (VRTX)?

In early February 2026, WuXi Biologics announced a license and research service agreement granting Vertex Pharmaceuticals exclusive global rights to develop and commercialize a preclinical trispecific T-cell Engager targeting B-cell mediated autoimmune diseases, with WuXi earning upfront, milestone, royalty, and R&D service revenues. This collaboration extends Vertex’s reach beyond cystic fibrosis into autoimmune therapies, highlighting its interest in next-generation immune-engaging...
NYSE:MAA
NYSE:MAAResidential REITs

Mid-America Apartment Communities Settlement Puts Revenue Software Practices In Focus

Mid-America Apartment Communities (NYSE: MAA) has agreed to a $53 million settlement to resolve a class action lawsuit related to its business practices. The agreement, which includes both financial and operational commitments, remains subject to court approval. The settlement covers MAA's use of revenue management software and may change if class member opt outs reach a high level. MAA is a large owner and operator of multifamily rental properties, so legal outcomes tied to its leasing and...